165 related articles for article (PubMed ID: 9827528)
1. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G
J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528
[TBL] [Abstract][Full Text] [Related]
2. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
4. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
[TBL] [Abstract][Full Text] [Related]
5. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression.
Harris HR; Rice MS; Shafrir AL; Poole EM; Gupta M; Hecht JL; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):96-102. PubMed ID: 29133366
[No Abstract] [Full Text] [Related]
7. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Risch HA
J Natl Cancer Inst; 1997 Nov; 89(22):1726-7. PubMed ID: 9390546
[No Abstract] [Full Text] [Related]
8. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.
Risch HA
J Natl Cancer Inst; 1998 Dec; 90(23):1774-86. PubMed ID: 9839517
[TBL] [Abstract][Full Text] [Related]
9. Ovulation and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Webb PM; Green AC
Int J Cancer; 2003 Mar; 104(2):228-32. PubMed ID: 12569579
[TBL] [Abstract][Full Text] [Related]
10. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Vine MF; Berchuck A
Cancer Causes Control; 2002 Nov; 13(9):807-11. PubMed ID: 12462545
[TBL] [Abstract][Full Text] [Related]
11. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
12. Incessant ovulation and ovarian cancer: a critical approach.
La Vecchia C; Franceschi S; Gallus G; Decarli A; Liberati A; Tognoni G
Int J Epidemiol; 1983 Jun; 12(2):161-4. PubMed ID: 6874210
[TBL] [Abstract][Full Text] [Related]
13. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
Modugno F; Ness RB; Wheeler JE
Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
[TBL] [Abstract][Full Text] [Related]
15. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
16. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
Risch HA; Marrett LD; Jain M; Howe GR
Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
[TBL] [Abstract][Full Text] [Related]
17. Ovulation, p53 mutations, and ovarian cancer--a causal link?
Whittemore AS; McGuire V
J Natl Cancer Inst; 1997 Jul; 89(13):906-7. PubMed ID: 9214665
[No Abstract] [Full Text] [Related]
18. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
19. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
20. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma.
Ouhtit A; Nakazawa H; Armstrong BK; Kricker A; Tan E; Yamasaki H; English DR
J Natl Cancer Inst; 1998 Apr; 90(7):523-31. PubMed ID: 9539248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]